Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection: Prospective Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Istanbul Bilgi University
- Enrollment
- 270
- Locations
- 1
- Primary Endpoint
- Dyspnea
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The aim of this study is to investigate the efficacy of pulmonary rehabilitation(PR) applied in the isolation processes of post-acute patients with mild and moderate symptoms who had positive COVID-19 test on dyspnea,muscle pain,chest expansion,lower limb muscle strength and dynamic balance,fatigue,anxiety and depression.
Detailed Description
This study was conducted with 270 patients who were the COVID-19 test was positive and isolated in their homes during post-acute periods.While one of the groups (n=135) was asked to remain isolated at home by providing patient education,a PR program was applied for 4 weeks in addition to the patients in the other group(n=135).PR consists of patient education, breathing, in-house mobilization and range of motion exercises.As the evaluation parameters,pre-treatment and post-treatment dyspnea levels with Borg scale,muscle pain with visual analog scale(VAS),functional capacities with sit-up test,chest expansions with tape measure,respiratory frequency,fatigue level with fatigue severity scale,and emotional status with hospital anxiety and depression(HAD) scale were evaluated.
Investigators
TOMRIS DUYMAZ
Assoc.Prof.
Istanbul Bilgi University
Eligibility Criteria
Inclusion Criteria
- •Between the ages of 28-45, positive COVID-19 test, being in the post-acute period, having symptoms of mild-moderate severity, respiratory rate ≤40 breaths / min, patients who can make video speech
Exclusion Criteria
- •Severe symptom involvement, fever more than 38 degrees, obese patients, patients with multiple comorbidities, patients with one or more organ failure, oxygen saturation in the blood ≤95%, a resting blood pressure of \<90/60 mmHg or\> 140 / 90 mmHg patients
Outcomes
Primary Outcomes
Dyspnea
Time Frame: Baseline, up to 4 weeks
The Borg scale is a scale scored between 0-10, indicating the severity of dyspnea. 0 indicates no shortness of breath, 10 indicates severe shortness of breath
Secondary Outcomes
- Fatigue severity(Baseline, up to 4 weeks)
- Hospital anxiety and depression scale(Baseline, up to 4 weeks)
- Chest expansion(Baseline, up to 4 weeks)
- Visual Analog Scale for pain(Baseline, up to 4 weeks)